INTRODUCTION
In just two decades the zebrafish, Danio rerio has been elevated from its erstwhile lowly status as one of the most common and prosaic of species found in the aquaria of tropical fish fanciers, into an experimental model of major significance for biomedical research. A key driver in this transformation has been the tractability of the zebrafish for genetic analysis. The same features-such as its ease of maintenance and prodigious spawning ability-that have made the species a favourite among beginner aquarists, together with the rapid and external development of its optically transparent embryos, have been exploited to great effect in a number of large-scale forward genetic screens, yielding a plethora of mutant strains (1) . Such mutants have provided the starting point for the analyses of a wide range of developmental processes, fuelling the 100-fold expansion of the zebrafish literature that has occurred since the late 1980s (source: PubMed). Just as these studies have established the legitimacy of the species as a model for vertebrate development, so too has grown the recognition that zebrafish can also be exploited for modelling human diseases (2) .
The list of diseases that are now being investigated using the zebrafish is already too long to permit a comprehensive survey in the space available here. In what follows I will instead focus on a few selected examples of recent studies, illustrating some of the experimental methods ( Fig. 1 ) that make the zebrafish increasingly one of the organisms of choice for the analysis of the cellular and molecular basis of human pathologies.
MODELS OF MUSCULAR DYSTOPHIES AND MYOPATHIES
The ease with which their skeletal muscles can be observed in situ, together with the isolation of a number of mutants with impaired motility (3) has stimulated the use of zebrafish as a model for the analysis of both myogenesis and myopathy. Following their earlier characterization of the dystrophin mutant, sapje (4), Currie and colleagues (5) have more recently described the identification of mutant alleles of the gene encoding the zebrafish extracellular matrix (ECM) protein laminin a2, providing a model for one of the most common forms of congenital muscular dystrophy, MDC1A. Although disruption of the mechanical link between the ECM and the cytoskeleton is widely regarded to be the underlying cause of many muscular dystrophies, definitive understanding of the underlying basis of MDC1A has been lacking. The two mutant alleles of the zebrafish laminin a2 gene, known as candyfloss, both have premature stop codons in the exon encoding the globular dystroglycan binding domain of lamininA2, a region close to the location of a number of disease associated mutations found in human patients. Embryos homozygous for either mutant allele display a stochastic but progressive detachment of muscle fibres as revealed by immunohistochemical staining at successive developmental stages. Notably, this effect can be suppressed by anaesthatising the mutant animals, suggesting that detachment is induced by mechanical stress. To test this hypothesis, the Currie group used a simple but clever assay in which the mutant larvae were made to swim through a viscous medium, thereby increasing the load on the fibres. As anticipated, this led to a significant enhancement of the phenotype, such that virtually every muscle fibre became detached. By analogy, these findings point to a failure in the maintenance of muscle attachments as the underlying cause of the dystrophic pathology in MDC1A patients, rather than an aberration in the proliferation or fusion of myobalsts or in the motor stimulation of muscle fibres, as has been variously suggested (5) .
As well as binding to dystroglycan, laminin A is also known to interact with integrin a7b1 in skeletal muscle. Mutations in the ITGA7 gene (that encodes the integrin a7 subunit) have previously been shown to be associated with a progressive muscular dystrophy in humans (6) . No mutant alleles of the itga7 gene have been identified in zebrafish, so Postel et al. (7) have employed the well established approach of morpholino antisense oligonucleotide injection (8) to 'knock down' integrin a7 expression in developing zebrafish embryos. Consistent with the effects in human and mouse, such knockdown causes a muscle detachment phenotype similar to that seen in sapje and candyfloss mutants (Fig. 2) . Integrins are connected to the actin cytoskeleton by the focal adhesion protein integrin linked kinase (Ilk), which binds both to the intracellular domain of the b1-integrin subunit and to the actin binding proteins paxillin, PINCH and b-parvin. Interestingly, Postel et al. (7) found that zebrafish homozygous for a loss of function mutation in the ilk gene display a dystrophic phenotype similar to that of the sapje and candyfloss mutants, indicating a role for Ilk in muscle fibre attachment, most likely through its interaction with the integrin a7b1 complex. The dystrophic phenotype manifests itself in ilk mutants significantly later than in candyfloss mutant embryos, a difference that the authors point out likely reflects the partially redundant roles played by integrin a7b1 and the DGC in mediating attachment of muscle fibres to the ECM. Consistent with this, morpholino mediated knockdown of dystroglycan in the ilk mutant embryos caused the fibre detachments to occur much earlier. However, the effects of itga7 knockdown are also manifest earlier than the ilk mutant phenotype, implying that Ilk acts to stabilize or strengthen the interaction between laminin A and the integrin receptor, but is not required to establish attachment between the muscle fibre and the ECM. This analysis-which exemplifies the precision with which pathological processes can be dissected using zebrafish mutants-confirms and extends the findings of a contemporaneous study of Ilk function in mouse (9), identifying ilk as a potential candidate gene for one of the several orphan congenital muscular dystrophies in human.
Ryanodine receptors (RYR1) are ion channels that play a key role in the release of Ca 2þ ions from the sarcoplasmic reticulum during muscle contractions. Mutations in the human RYR1 gene have been shown to cause one form of the myopathy known as multi/minicore disease (MmD), a condition characterized by muscle weakness and small regions of sarcomeric disorganization, so-called minicores, within muscle fibres (10) . Two genes encoding orthologues of RYR1 have been identified in zebrafish, one (ryr1a), expressed specifically in slow-twitch muscles, the other (ryr1b) expressed specifically in fast-twitch muscles (11) . The spontaneously arising mutant relatively relaxed (ryr) mutant was isolated from a wild-type laboratory stock on the basis of its slower swimming behaviour, and found to be caused by an insertion in the ryr1b gene (11) . The insertion results in aberrant splicing of the ryr1b mRNA, introducing a premature stop codon into the coding sequence: consistent with the expected consequent loss of RYR1 activity, muscles of mutant animals exhibit smaller calcium transients-measured using calcium indicator dyes in live embryos-than their wild-type siblings and display weaker contractions. In addition, the fast muscle fibres exhibit minicores similar to those associated with the human pathology.
Other forms of MmD are caused by mutations in the human SEPN1 gene that encodes a selenoprotein of unknown function (12) . Using morpholinos, Jurynec et al. (13) compared the effects of loss of SEPN1 activity with knockdown of the RYR1a and RYR3 genes in zebrafish and found strikingly similar defects in the morphology of slow-twitch muscle fibres. Moreover, by injecting a fluorescent calcium indicator dye into wild-type and morphant embryos, they found that loss of both RYR and SEPN1 activities has a significant effect on calcium mobilization, suggesting that the similar effects of SEPN1 and RYR dysfunction on muscle fibres reflect their involvement in a common biochemical pathway. In line with this, RYR can be co-immunoprecipitated with FLAG-tagged SEPN1 expressed in wild-type embryos; and RYR activity-assayed by binding of tritiated ryanodine, a plant alkaloid that binds specifically to activated RYRs-is reduced in embryos injected with the SEPN1 morpholino. These studies have thus shed new light on the molecular mechanisms underlying the genetic diversity of MmD.
MODELS OF NEURODEGENERATIVE DISEASE
Goldberg-Shprintzen syndrome is a rare but severe and currently untreatable human neurological disorder caused by mutations in the gene encoding KBP, the Kinesin family1 binding protein (14) . So far, analysis of KBP function has been limited to tissue culture based assays but new insights into the cellular consequences of KBP dysfunction have now been provided by the analysis of a zebrafish mutant for KBP (15) . This mutation was isolated in a forward genetic screen specifically designed to detect defects in myelinated axons, using a simple in situ hybridization protocol to visualize glial cells (16) . The absence of glia along the lateral line-a sensory structure that runs the length of the main body axis-in the KBP mutant is accompanied by a truncation of the posterior lateral line (PLL) axons that they ensheath. This latter defect could be a consequence of the lack of myelinating glial cells, but alternatively, the lack of glia could be due to the defective axon. To distinguish between these possibilities, fluorescently labelled wild-type cells were transplanted into mutant embryos; in some case such cells gave rise to PLL neurons that extended their axons along the entire length of the mutant animal, indicating that KBP function within the neuron is sufficient for the normal outgrowth or maintenance of the axon. To observe whether mutation of KBP affects the dynamics of axon outgrowth, a transgene that drives expression of GFP specifically in neurons was crossed into the mutant background and the resulting embryos imaged by time-lapse con-focal microscopy. These movies revealed that outgrowth of the PLL (and other) axons is significantly retarded in mutant embryos, their growth cones showing an aberrant alternation between forward growth and retraction. The underlying cause of this aberrant behaviour seems to be a major disorganization of microtubules, suggesting this to be the primary effect of the KBP dysfunction. This contrasts with the conclusions of previous studies that pointed to a role for KBP in regulating mitochondrial transport through its direct interaction with the Kinesin family1 protein Kif1ba (15) .
Another process implicated in neurodegenerative disorders is the overactivation of microglia, the specialized immune cells that reside in the central nervous system. These cells are normally responsible for recognizing and removing dying neurons, but when dysregulated they release reactive oxygen species causing aberrant neurotoxicity (17) . There is thus much interest in understanding the mechanisms underlying microglia behaviour, in particular with a view to developing novel targeted therapeutic interventions. Using the zebrafish, Peri and Nüsslein-Volhard (18) have established an in vivo model of neuronal phagocytosis by microglia and used this to uncover a novel and unexpected role for the vacuolar (V-type) ATPase in this process. The authors first generated an Apo-E -GFP transgene to mark the migroglia which, together with a neuronal specific DsRed transgene to mark neurons (Fig. 3) , enabled them to visualize the capture and subsequent ingestion of apoptotic neurons by microglia in the developing brain. A key event in the phagocytic process is the acidification of phagosomes, the vesicles containing the ingested material. The V-type ATPases are the major proton pumps involved in the acidification of intracellular compartments; using morpholino oligonucleotides, the authors knocked down the expression of the a1 subunit of the V-type ATPase and used the LysoSensor fluorophor to assay the effects on phagosome acidification. Surprisingly, this revealed no difference in acidification of vesicles between morphant and wild-type mircoglia; however, there was, a significant increase in the number of vesicles containing neuronal material in the morphant microglia, suggesting an inability of the cells to digest the material they have ingested. By incubating embryos with the lysosome-specific fluorescent dye DQ-BSA, the phagosomes in wild-type microglia were seen to undergo heterotypic fusion with lysosomes, giving rise to so-called phagolysosmes in which the neuronal material is digested. In contrast, few if any such vesicles were observed in the microglia of morphant embryos, indicating that the V-type ATPase a1 subunit is essential for this process. This remarkable study highlights the power of the zebrafish as a model system for elucidating the cell biology of pathogenic processes in an in vivo context as well as providing an important new model for the analysis of the role of microglia in neurodegenerative disease.
RECENT TECHNOLOGICAL ADVANCES
Although mutant alleles isolated in forward genetic screens have proven to be extremely effective in modelling human pathologies in the zebrafish, there is no question that the ability to target the inactivation of specific genes has established the mouse as the organism par excellence for human disease modelling. Although the lack of the enabling ES cell technology in zebrafish has been mitigated to some extent by the use of morpholinos, this approach has its limitations, not least the potential for non-specific 'off target' effects of the reagents along with the consequent need to perform careful titration and multiple controls for specificity of the injected oligonucleotides (8) . Moreover, the essentially transient nature of the attenuation of gene function achieved by morpholino injection effectively limits their application to the earliest stages of the life cycle, precluding the establishment of models of late onset disease or progressive tissue degeneration or repair. One approach to addressing this limitation of the zebrafish has been the application of targeting induced local lesions in genomes (TILLING) to the isolation of mutant alleles of orthologues of human disease associated genes. TILLING involves the identification of randomly induced (usually chemically) mutations in the gene of interest (19) . Although both cost and labour intensive, typically involving the resequencing of the relevant genomic sequence from thousands of progeny of mutagenized fish, it is a powerful approach and has led to the isolation of mutant alleles of a number of important loci. The high cost and requirement for dedicated sequencing facilities has, however, limited the implementation of TILLING programmes to a relatively few centres around the world; and with demand for mutant alleles oustripping supply, there has been a need for alternative reverse genetic approaches in the zebrafish. Two papers published within the past 12 months suggest that the application of zinc finger nucleases (ZFNs) may fulfil this need (20, 21) . ZFNs are hybrid proteins that combine the sequence-specific DNA binding activity of zinc fingers with the double stranded DNA break inducing activity of an endonuclease. The zinc fingers are engineered to recognize and bind to a target sequence within a gene of interest; once bound, the endonuclease induces a double stranded break which when repaired by non-homologous end-joining, results in the disruption of the gene. Remarkably, this approach that has been developed in tissue culture systems and applied with some success in whole organisms, including Caenorhabditis elegans and Drosophila (22) , has now been shown to be highly efficacious in zebrafish; injection of mRNA encoding the ZFNs into newly fertilized embryos results in a high frequency of adults that transmit mutations in the targeted gene through their germ line. Although the methods for selecting the appropriate zinc fingers require optimization, this opens up the prospect of generating mutant alleles of any gene of interest in the zebrafish. Moreover, since double stranded breaks can be repaired by homologous recombination it should, in principle, be able to introduce specific lesions-for instance, base changes associated with specific human disease alleles-into target loci.
Another important weapon in the mouse geneticist's armoury has been the ability to induce transgene expression in both a spatially and temporally regulated fashion. Such methods allow, for instance, the expression of oncogenes to be targeted to specific cell populations in a manner that does not compromise the early development of the organism, thereby facilitating analysis of their oncogenic effects. Although heat shock promoters have been used with some success in the zebrafish to induce transgene expression, restricting their activation to specific cell populations is technically challenging and not feasible on a large scale. Emelyanov and Parinov (23) have now adapted an estrogen receptor based inducible system, first established in plants, to achieve both spatial and temporal control of transgene expression in zebrafish. The system utilises a fusion of the DNA binding domain of the bacterial transcription factor LexA to the ligand binding domain of the human progesterone receptor (PR) that renders the DNA binding activity hormone dependent. In the absence of hormone, expression of this fusion protein has no effect in transgenic fish, but the incubation of the transgenic animals with the synthetic steroid, mifepristone (RU-486), allows the hybrid transcription factor (which also includes an activation domain) to bind to its target sequences. In this way, genes of interest encoded by transgenes containing such LexA biding sites upstream of their coding sequences can be activated at the desired stage; and this activation can be restricted to specific cell populations by driving expression of the LexA -PR fusion with an appropriate spatially restricted enhancer. As proof or principle, the authors successfully employed this system to induce the expression of an activated K-Ras transgene specifically in skin epithelial cells, causing an oncogenic like transformation of the cells. The potential of this system for the controlled induction of disease causing genes in large numbers of fish is clear; such animals could be employed in high-throughput screens of small molecules for novel therapeutic leads, an approach to which the zebrafish is especially well suited (24) .
